Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Nobuto Tsuneyama"'
Autor:
Hiroshi Arinami, Yuichiro Watanabe, Yutaro Suzuki, Misuzu Tajiri, Nobuto Tsuneyama, Toshiyuki Someya
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract The pathophysiology underlying major depressive disorder (MDD) and schizophrenia is related to endocrine system functions and includes changes in the blood levels of cortisol and insulin-like growth factor 1 (IGF-1). However, these hormones
Externí odkaz:
https://doaj.org/article/69df3b1fff6e4e4f89814cbe369f0f25
Publikováno v:
BMC Psychiatry, Vol 21, Iss 1, Pp 1-6 (2021)
Abstract Background Hormones of the hypothalamic–pituitary–gonadal (HPG), hypothalamic–pituitary–adrenal (HPA), and hypothalamic–pituitary–somatotropic (HPS) axes are potentially involved in major depressive disorder (MDD), but these horm
Externí odkaz:
https://doaj.org/article/69ad04d935d34ffca48d8f6a981721d1
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0199922 (2018)
It has long been known that antipsychotic drugs (ATP) causes tachycardia, however details such as the differences between ATP are not well known. In recent years, the relationship between the rise in resting heart rate (RHR) and the increased risk of
Externí odkaz:
https://doaj.org/article/2a37425257584fd58991379242aad5ad
Autor:
Nobuto Tsuneyama, Yutaro Suzuki, Kazushi Sawamura, Takuro Sugai, Naoki Fukui, Junzo Watanabe, Shin Ono, Mami Saito, Toshiyuki Someya
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0149518 (2016)
Olanzapine (OLZ) treatment is associated with a high risk of weight gain, and may cause abnormalities in glycolipid metabolism. Therefore, the underlying mechanism of OLZ-related weight gain is needed to clarify but not yet been adequately determined
Externí odkaz:
https://doaj.org/article/a91ccf674676457d944a36c42098e1b1
Publikováno v:
Journal of Clinical Psychopharmacology. 39:367-371
BACKGROUND Insulin-like growth factor I (IGF-I) is a neurotrophic factor produced by the hypothalamic-pituitary-somatotropic axis and is considered a potential contributor to the pathology of major depressive disorder (MDD). Although it is known that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfc7929340b5d0dbb5928aa4c51b8c45
https://doi.org/10.1097/jcp.0000000000001071
https://doi.org/10.1097/jcp.0000000000001071
Publikováno v:
BMC Psychiatry
BMC Psychiatry, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Psychiatry, Vol 21, Iss 1, Pp 1-6 (2021)
Background Hormones of the hypothalamic–pituitary–gonadal (HPG), hypothalamic–pituitary–adrenal (HPA), and hypothalamic–pituitary–somatotropic (HPS) axes are potentially involved in major depressive disorder (MDD), but these hormones have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a00087d429d0b841521a4709a56051e5
https://pubmed.ncbi.nlm.nih.gov/33731067
https://pubmed.ncbi.nlm.nih.gov/33731067
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 7, p e0199922 (2018)
PLoS ONE, Vol 13, Iss 7, p e0199922 (2018)
It has long been known that antipsychotic drugs (ATP) causes tachycardia, however details such as the differences between ATP are not well known. In recent years, the relationship between the rise in resting heart rate (RHR) and the increased risk of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::446bee7c8c94b08585c931f884f06b80
https://pubmed.ncbi.nlm.nih.gov/30016331
https://pubmed.ncbi.nlm.nih.gov/30016331
Autor:
Misuzu Tajiri, Nobuto Tsuneyama, Shin Ono, Toshiyuki Someya, Takuro Sugai, Mami Saito, Yutaro Suzuki, Naoki Fukui, Junzo Watanabe
Publikováno v:
Journal of clinical psychopharmacology. 37(4)
BACKGROUND Users of antipsychotics (APs) have a risk of sudden cardiac death (SCD). Sudden cardiac death in such patients is thought to be largely due to drug-induced QT prolongation. It has been reported that many subjects with drug-induced torsades
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a6e4ed7d1082e3dc1dcc37292e811b9
https://pubmed.ncbi.nlm.nih.gov/28590366
https://pubmed.ncbi.nlm.nih.gov/28590366
Autor:
Toshiyuki Someya, Y Inoue, Naoki Fukui, Nobuto Tsuneyama, Takuro Sugai, Junzo Watanabe, Mami Saito, Shin Ono, Yutaro Suzuki
Publikováno v:
The Pharmacogenomics Journal. 14:452-456
Risperidone (RIS) is a frequently used efficacious psychotropic drug. However, it prolongs the QTc interval and may cause fatal arrhythmia. Little is known on the determinants of this RIS side effect. RIS is metabolized by CYP2D6, and is subject to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9642d511e718368b0b34535b281002c
https://doi.org/10.1038/tpj.2014.6
https://doi.org/10.1038/tpj.2014.6
Autor:
Yutaro Suzuki, Shin Ono, Takuro Sugai, Naoki Fukui, Nobuto Tsuneyama, Toshiyuki Someya, Junzo Watanabe, Kazushi Sawamura
Publikováno v:
The Journal of Neuropsychiatry and Clinical Neurosciences. 27:162-164
Association between gastric inhibitory polypeptide receptor polymorphism, rs10423928, and body mass index in olanzapine-treated schizophrenia was examined. Body mass index change for the A/T+A/A genotypes was significantly higher than that for the T/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ce52625ea70d836e180cdcb084a83f6
https://doi.org/10.1176/appi.neuropsych.13120389
https://doi.org/10.1176/appi.neuropsych.13120389